Attached files
| file | filename |
|---|---|
| 10-Q - PRIMARY DOCUMENT - Kraig Biocraft Laboratories, Inc | KBLK10Q2017Q3.htm |
| EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - Kraig Biocraft Laboratories, Inc | exhibit321and322.htm |
Exhibit 31.1
Chief
Executive Officer Certification (Section 302)
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER
Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002
I, Kim
Thompson, certify that:
(1) I
have reviewed this quarterly report on Form 10-Q of Kraig Biocraft
Laboratories, Inc., (Registrant).
(2) Based
on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading
with respect to the period covered by this quarterly
report;
(3) Based
on my knowledge, the financial statements and other financial
information included in this quarterly report, fairly present in
all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the
periods presented in this quarterly report;
(4) The
registrants other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and have:
(a) designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, is
made known to us by others within those entities, particularly
during the period in which this quarterly report is being
prepared;
(b) evaluated
the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the
end of the period covered by this report based on such evaluation;
and
(c)
disclosed in this report any changes in the registrant’s
internal control over financial reporting that occurred during the
registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an
quarterly report) that has materially affected, or is reasonably
likely to materially affect, the registrant’s internal
control over financial reporting; and
(5) The
registrant’s other certifying officers and I have disclosed,
based on our most recent evaluation of the internal control over
financial reporting, to the registrant’s auditors and the
audit committee of registrant’s board of directors (or
persons performing the equivalent functions):
(a) all
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to
record, process, summarize and report financial information ;
and
(b) any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrants internal
control over financial reporting.
Date:
November 15, 2017
|
|
By:
|
/ s / Kim
Thompson
|
|
|
|
|
Kim
Thompson
|
|
|
|
|
CEO, CFO,
President |
|